Bowie Alfred Lloyd Jr. 4
4 · Eikon Therapeutics, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Bowie Alfred Lloyd Jr.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-03-02+67,044→ 67,044 totalExercise: $14.88Exp: 2036-03-01→ Common Stock (67,044 underlying)
Footnotes (1)
- [F1]1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.
Signature
/s/ Benjamin Thorner, Attorney-in-Fact|2026-03-04